- Patient-reported outcomes and quality of life in PMM2-CDG(2022)
Auteurs: Eva Morava
Pagina's: 145 - 151
- Expanding the phenotypic spectrum of BCS1L-related mitochondrial disease(2021)
Auteurs: Eva Morava
Pagina's: 2155 - 2165
- Therapeutic approaches in Congenital Disorders of Glycosylation (CDG) involving N-linked glycosylation: an update(2020)
Auteurs: Peter Witters, Eva Morava
Pagina's: 268 - 279
- Hypophosphatasia in adults: clinical spectrum and its association with genetics and metabolic substrates(2020)
Auteurs: Peter Witters, Evelien Gielen, Annick Vanclooster, Wouter Meersseman, Eva Morava, David Cassiman, Michaël Laurent
Pagina's: 340 - 348
- Research activity and capability in the European reference network MetabERN(2019)
Auteurs: Eva Morava
- The metabolic map into the pathomechanism and treatment of PGM1-CDG(2019)
Auteurs: Silvia Radenkovic, Matthew Bird, Peter Witters, Pieter Vermeersch, David Cassiman, Eva Morava, Bart Ghesquière
Pagina's: 835 - 846
- Long-term follow-up in PMM2-CDG: are we ready to start treatment trials?(2019)
Auteurs: Peter Witters, Gert Matthijs, Wouter Meersseman, David Cassiman, Eva Morava
Pagina's: 1181 - 1188
- Propeptide glycosylation and galectin-3 binding decrease proteolytic activation of human proMMP-9/progelatinase B(2019)
Auteurs: Lise Boon, Jennifer Vandooren, Vasily Rybakin, Peter Witters, Eva Morava, Paul Proost, Ghislain Opdenakker
Pagina's: 930 - 945
- The challenge of CDG diagnosis(2019)
Auteurs: Eva Morava
Pagina's: 1 - 5
- International clinical guidelines for the management of phosphomannomutase 2-congenital disorders of glycosylation: Diagnosis, treatment and follow up(2019)
Auteurs: David Cassiman, Peter Witters, Eva Morava
Pagina's: 5 - 28